key: cord-1026039-h9jm242m
authors: Law, J. C.; Koh, W.; Budylowski, P.; Lin, J.; Yue, F.; Abe, K. T.; Rathod, B.; Girard, M.; Li, Z.; Rini, J. M.; Mubareka, S.; McGeer, A.; Chan, A. K.; Gingras, A.-C.; Watts, T. H.; Ostrowski, M.
title: Systematic examination of T cell responses to SARS-CoV-2 versus influenza virus reveals distinct inflammatory profile
date: 2020-09-01
journal: nan
DOI: 10.1101/2020.08.27.20183319
sha: c9c1d16470609b3bfc3f140b595342631cbccb5b
doc_id: 1026039
cord_uid: h9jm242m

There is a pressing need for an in-depth understanding of immunity to SARS-CoV-2. Here we investigated T cell recall responses to fully glycosylated Spike trimer, recombinant N protein as well as to S, N, M and E peptide pools in the early convalescent phase. All subjects showed SARS-CoV-2-specific T cell responses to at least one antigen. SARS-CoV-2-specific CD4+ T cells were primarily of the central memory phenotype and exhibited a lower IFN-[gamma] to TNF-[alpha] ratio compared to influenza-specific responses of the same donors, independent of disease severity. SARS-CoV-2-specific T cells were less multifunctional than influenza-specific T cells, particularly in severe cases, potentially suggesting exhaustion. High IL-10 production was noted in response to N protein, possibly contributing to immunosuppression, with potential implications for vaccine design. We observed granzyme B+/IFN-[gamma] CD4+ and CD8+ proliferative responses to peptide pools in most individuals, with CD4+ responses predominating over CD8+ responses. Peripheral T follicular helper responses to S or N strongly correlated with serum neutralization assays as well as RBD-specific IgA. Overall, T cell responses to SARS-CoV-2 are robust, however, CD4+ Th1 responses predominate over CD8+ responses and are more inflammatory with a weaker Tfh response than influenza-specific CD4+ responses, potentially contributing to COVID-19 disease.

RBD-specific IgA but were less frequent than those observed in response to influenza. Our study 93 reveals new insights into the recall response of SARS-Cov-2 in the early convalescent phase, 94 highlighting that SARS-CoV-2-specific CD4+ T cell responses are more inflammatory and show 95 a weaker pTfh response than influenza A-specific CD4+ recall responses within the same donors. 96 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted September 1, 2020. . https://doi.org/10.1101/2020.08.27.20183319 doi: medRxiv preprint

Thirteen COVID-19 convalescent donors who had recently tested positive for SARS-CoV-2 by 99 PCR, and a single SARS-CoV-1 patient from 2003 were consented for leukapheresis to obtain 100 plasma and PBMC (Table 1) . Samples for SARS-CoV-2 convalescent individuals were collected 101 from 27 days to 90 days post onset of symptoms. Disease severity ranged from asymptomatic, 102 mild (non-hospitalized), moderate (hospitalized not ICU) to severe (ICU). The average age was 103 53 (range 31-72), and 8 out of 13 were male ( Table I) . To date, most studies have used overlapping peptide pools to assess antigen-specific T cell 108 responses to SARS-CoV-2. Here we used intact glycosylated S from SARS-CoV-2 and seasonal 109 human CoV-OC43 (OC43), as well as recombinant E. coli expressed SARS-CoV-2 N to determine 110 how T cells respond functionally to SARS-CoV-2 under conditions where antigen processing is 111 required. Intracellular cytokine staining (ICC) of ex vivo PBMC was conducted to determine the 112 frequency of IFN-g, TNF-α and IL-2-producing cells, with the gating strategy shown in Figure  113 S1A. Following 18hrs of stimulation, with GolgiStop and GolgiPlug added for the last 6 hrs, 114 SARS-CoV-2 S-specific CD4+ T cells were detected in 54% of donors based on IFN-g production, 115

75% of donors based on TNF-α production and 85% of donors based on IL-2 production. N-116 specific CD4+ T cells were detected in 38% of donors based on IFN-g, 58% based on TNF-α, and 117 54% of donors based on IL-2 production ( Figure 1A -C, Table I S1) . Overall, 92% of donors 118 showed a specific CD4+ T cell response to at least one SARS-CoV-2 protein based on production 119 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted September 1, 2020. . https://doi.org/10.1101/2020.08.27.20183319 doi: medRxiv preprint of at least one cytokine, where a positive response was defined as a 10% increase over control 120 stimulated samples (Table SI) . No responses were detected to OC43 spike protein by ICC in the 121 same donors (Figure S1B) , whereas 100% of donors produced cytokines in response to 122 PMA/ionomycin ( Figure S1B) . We did not observe cytokine production in CD8+ T cells from any 123 of the donors, albeit CD8+ T cells from all donors responded to influenza A/PR8/34 virus (PR8) 124 as well as to PMA/ionomycin (data not shown). This is likely because CD8+ T cells respond poorly 125 to whole protein antigens. Taken together, our data show that the vast majority of SARS-CoV-2 126 convalescent individuals have recall CD4+ responses to SARS-CoV-2 S or N proteins at 4-10 127 weeks after initial symptoms, with IL-2 and TNF-a predominating over 129

multiparameter flow cytometry 131

As most adults are expected to have memory T cells specific for seasonal influenza virus, we 132 compared recall responses to influenza A/PR8/34 H1N1 virus (PR8) for all donors. 92% of SARS-133

CoV-2 convalescent patient samples showed strong CD4+ recall responses to PR8 stimulation 134 based on IFN-g producing T cells and the frequency of these responding cells was substantially 135 higher than responses to S and N proteins ( Figure 1A) . This was not due to insufficient S protein, 136 as increasing the dose from 1 to 5µg per ml did not increase the frequency of responses ( Figure  137 S2A). We also obtained similar responses using trivalent inactivated seasonal influenza vaccine 138 (TIV), which contains only influenza proteins ( Figure S2B) . Thus, the weaker response to SARS-139

CoV-2 S protein compared to influenza proteins is unlikely due to the use of live influenza virus 140 versus recombinant SARS-CoV-2 proteins, albeit it could be impacted by an incomplete set of 141 SARS-CoV-2 epitopes covered by including only 2 of the SARS-CoV-2 proteins. Some human T 142 cell studies use costimulation with anti-CD49d and anti-CD28 to increase the sensitivity of 143 detection with ICC (32), however we found no difference in the frequency of response to S with 144 or without additional costimulation ( Figure S2C) . We also repeated the assays 3 times for 2 of the 145 donors and obtained a similar frequency of responding T cells each time ( Figure S2D ). In contrast 146 to the results with SARS-CoV-2 convalescent patients, PBMC collected from healthy donors in 147 early March 2020 did not show detectable T cell responses to S, N or OC43 S whole proteins, 148 albeit all the healthy donors responded to PR8 ( Figure S3 ). As will be discussed below, the lack 149 of detection of cross-reactivity in healthy donors may reflect the relative insensitivity of the ICC 150 assay compared to other methods of detecting cross-reactivity. 151

152 Analysis of T cell production of multiple cytokines showed that 80% of S-specific CD4+ T cells 153 produced only 1 cytokine. Influenza-specific CD4+ T cell responses were more multifunctional, 154 with 8.7% of PR8-specific CD4+ T cells as compared to 3.4% of S-specific T cells producing all 155 3 cytokines (Figure 2A) . We also noted that the ratio of IFN-g to TNF-α producing cells was 156 significantly higher among the PR8-specific CD4+ T cells than the S-specific CD4+ T cells 157 ( Figure 2B ) and this was independent of disease severity. 158 159 Analysis of CD27 and CD45RA expression on the S-specific and PR8-specific TNF-α-producing 160 CD4+ T cells indicated that the responding T cells were predominantly central memory T cells 161 ( Figure 2C) . The activation markers HLA-DR and 4-1BB are frequently used to determine 162 specific recall responses. Based on these markers, 100% of donors responded to influenza PR8, 163

whereas 69% responded to Spike and 85% to N. Examination of HLA-DR/4-1BB double positive 164 cells for cytokine production showed some discordance between activation markers and cytokine 165 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted September 1, 2020. . https://doi.org/10.1101/2020.08.27.20183319 doi: medRxiv preprint producing cells (Figure 2D) , with neither approach identifying 100% of the responding CD4+ T 166 cells. 167

Although there appeared to be a trend towards higher responses in donors with severe illness in 169 the first 4 weeks, using either activation markers and/or production of cytokines as a measure of 170 response, differences in ICC response based on disease severity were not significant ( Figure 2E) . 171

Taken together, our data show that SARS-CoV-2-specific T cells from patients in the early 172 convalescent phase are largely of the Tcm phenotype and respond to S and N proteins with a higher 173 ratio of TNF-a:IFN-g producing cells compared to the response to influenza virus, which shows a 174 more typical anti-viral IFN-g dominant response. 175

176

To further analyze cytokine production during recall responses to SARS-CoV-2 we collected 178 supernatants from ex vivo PBMC 48hrs post-stimulation with S, N or influenza PR8 by multiplex 179 bead array analysis of 13 cytokines (Figures 3, S4) . 92% of SARS-CoV-2 convalescent donors 180 showed IFN-g production in response to SARS-CoV-2 S, whereas 100% showed IFN-g responses 181 to SARS-CoV-2 N and PR8, albeit the median level of IFN-γ in response PR8 was higher than that 182 observed in response to SARS-CoV-2 N or S (Figure 3A, S4A) . 100% of patient PBMC produced 183 specific TNF-α responses in response to N, whereas 50% produced TNF-α in response to Spike 184 and 92% in response to PR8. N-specific responses showed substantially higher TNF-α responses 185 than S or PR8-specific responses (Figure 3B, S4A) . IL-2 was produced in response to S or PR8, 186 but not in response to N-stimulation, whereas IL-10 was produced in all cases, albeit the highest 187 amount of IL-10 was observed in the N-stimulated cultures (Figure 3 C, D, S4A) . IL-13 was 188 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted September 1, 2020. . https://doi.org/10.1101/2020.08.27.20183319 doi: medRxiv preprint produced in response to S and PR8, but not N, whereas IL-6 was only observed with S and N 189 restimulation and not with PR8 (Figure 3 E, F) . Similar to our findings with ICC, the ratio of g to TNF-α or IL-10 was highest in cultures stimulated with Influenza A virus ( Figure 3G) . We 191 did not detect IL-4, 5 or 17F in any of the cultures (data not shown). IL-9 and 17A were detected 192 in some cultures but did not show consistent increases with S or N stimulation, whereas IL-22 was 193 produced in response to S stimulation for some donors ( Figure S4B ). Healthy donor PBMC 194 produced IL-6, 10, IFN-g and TNF-α in response to N but not S proteins ( Figure S4C ). Stimulation 195 of SARS-CoV-2 convalescent PBMC as well as healthy donor PBMC with OC43 S protein 196 resulted in induction of IFN-g, TNF-a, IL-10 and IL-6, but not IL-2 ( Figure S5A, B) . is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted September 1, 2020. . https://doi.org/10.1101/2020.08.27.20183319 doi: medRxiv preprint expression to detect antigen-specific pTfh cells in SARS-CoV-2 convalescent patient PBMC 212 following restimulation with S, N or PR8 ( Figure 4A ). 46% of samples showed S-specific IL-2 213 producing pTfh, 54% N-specific and 100% of PBMC samples showed PR8-specific pTfh. For 214 samples collected during the first 4 weeks post-symptoms, pTfh responses to S were higher in 215 severe compare to mild cases (Figure 4A, B) . We also compared pTfh responses of PBMC from 216 the SARS-CoV-2 convalescent patients with IgG and IgA responses to N and RBD based on serum 217 ELISA (36) and neutralization data (Figure 4C,D) . There was a positive correlation between the 218 frequency of IL-2+pTfh and N-specific IgG (R=0.57, p<0.05). The correlation between IL-2+pTfh 219 and RBD-specific IgG showed a similar positive trend (R=0.29) but did not reach statistical 220 significance. Similarly, no significant correlation with S-specific IgG was observed (data not 221 shown). There was a significant positive correlation between the pTfh response to RBD-specific 222 IgA (R=0.66, p< 0.05). There was also a strong correlation between WT SARS-CoV-2 IC50 223 neutralization (modified PRNT assay) by patient sera and the pTfh response (R=0.84, p<0.001). 224 IgG (R=0.36), albeit not significant ( Figure 5A) . There was also a positive correlation between 231 IL-2+ CD4+ and RBD-specific IgA (R=0.60, p<0.05) ( Figure 5B) . A strong positive correlation 232 was also found between virus neutralization and IL-2+ CD4+ T cells (R=0.82, p<0.001), and 233 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted September 1, 2020. . https://doi.org/10.1101/2020.08.27.20183319 doi: medRxiv preprint between S-RBD IgG AUC and IL-2+ CD4+ T cells. (Figure 5C ). There was also a positive 234 correlation between virus neutralization and disease severity ( Figure 5D) . 235 236 Thus, pTfh responses can be detected in 6 out of 13 SARS-CoV-2 convalescent PBMC responding 237 to S protein, 7/13 in response to N whereas 13/13 showed a Tfh response to influenza A virus. 238

Both pTfh and T effector responses correlated strongly with the neutralization titers observed in 239 the same donors, with the highest neutralization activity correlating with disease severity. shown in Figure S6 ). Proliferation responses of total T cells to at least one antigen was observed 250 in 12/13 donors (Table S2 ). There was considerable variability between donors. Generally, donors 251 who made strong proliferative responses had strong responses to all antigens tested. However, 252 antigen-specific proliferation did not correlate significantly with disease severity (Figure 6B , C, 253 D). We also examined PBMC from a SARS-CoV-1 patient taken 17 years post-illness and 254 observed modest reactivity to the N peptide pool (Figure 6B, C) . We next broke down responses 255 into CD4+ and CD8+ T cell responses for each peptide pool. For most subjects and antigens, CD4+ 256 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted September 1, 2020. . https://doi.org/10.1101/2020.08.27.20183319 doi: medRxiv preprint T cell proliferative responses were substantially higher than CD8+ T cell responses, independent 257 of disease severity ( Figure 6E) . 258 259 Although CD8+ cytotoxic T cells are classically associated with virus-infected cell killing, CD4+ 260 granzyme+ cytotoxic T cells can be a significant part of the human anti-viral T cell responses (37, 261 39-41). Therefore, we also assessed IFN-g and granzyme B levels by flow cytometry in the 262 CFSE low responding CD4+ and CD8+ T cells (Figure 7A, B) . Of note, the samples from subjects 263 with severe and moderate disease tended to have a higher proportion of CD4+ IFN-g/granzyme B 264 co-producing T cells than mild, however this was not universally the case, as we also saw a high 265

proportion of IFN-g/granzyme B expressing T cells in the asymptomatic donor. 266

The frequency of proliferating IFN-g/granzyme B co-producing T cells in response to S peptide 268 pools correlated with the frequency of IL-2 producing pTfh in response to intact Spike ( Figure 7C ) 269 as well as with virus neutralization titers ( Figure 7D ). In addition, proliferating IFN-g/granzyme B 270 producing cells in response to E or M peptide pools correlated with serum neutralization titers 271 (Figure 7 E, F). Thus, a strong CD4+ response overall, whether based on analysis of whole protein 272 or peptide stimulation, correlates with strong neutralization responses. 273 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted September 1, 2020. indistinguishable frequencies of responding CD4+ T cells producing IFN-g, TNF-a and IL-2 296 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted September 1, 2020. . https://doi.org/10.1101/2020.08.27.20183319 doi: medRxiv preprint whether samples were restimulated with live influenza virus or with TIV, the inactivated influenza 297 vaccine which is dominated by the hemagglutinin protein. It is unlikely that the altered cytokine 298 response in response to SARS-CoV-2 antigens is driven by disease severity, as mild and severe 299 patients were distributed throughout the plots showing this altered ratio (Fig. 2B, 3G ). On the other 300 hand, the lower frequency of multifunctional cells in the SARS-CoV-2 specific as compared to 301 influenza A-specific CD4+ recall responses seems to be heavily weighted by the severe cases (Fig.  302 2B) and could reflect COVID-19-specific exhaustion, as has been suggested by other studies based 303 on activation/exhaustion markers (42, 43). The influenza-specific recall responses we observed are 304 likely due to a lifetime of seasonal exposure and/or vaccination, whereas the SARS-CoV-2-305 specific responses are more recent. However, it is unlikely that the time since exposure is driving 306 the altered cytokine profile we observe, as the cytokine profile observed in recall responses 307 generally reflects the epigenetic profile imprinted during priming (44). 308 309 Multiplex analysis of cytokines in supernatants of PBMC following SARS-CoV-2 antigen 310 stimulation also revealed lower IFN-g to TNF-a ratios of SARS-CoV-2 compared to influenza-311 specific responses as well as higher levels of IL-10 and IL-6. The ICC flow cytometry assay allows 312 one to clearly identify the source of the cytokines as CD4+ T cells, whereas the multiplex cytokine 313 assay reflects total amount of secreted cytokine and can also reflect cytokines secreted from other 314 cells, such as monocytes or NK cells, in response to the activated T cells. IL-10 can be produced 315 by both T cells and antigen presenting cells, whereas IL-6 is likely coming from monocytes 316 responding to the activated T cells in the PBMC culture. Particularly striking in our study was the 317 high level of IL-10 detected in the supernatants of N-stimulated cultures, which could contribute 318 to impaired antigen presentation and immunosuppression (45). Further investigation is required to 319 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted September 1, 2020. here with antigen-specific T cell responses. They also noted Th17 responses, which were not 337 consistently observed in the antigen-specific T cells in our cohort. 338 339 Of note, we observed a disconnect between ICC responses and analysis of T cell responses to S 340 and N based on activation markers. This was not unique to SARS-CoV-2, however, as we observed 341 a similar disconnect with influenza A-specific T cell cytokine response and activation markers 342 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted September 1, 2020. . https://doi.org/10.1101/2020.08.27.20183319 doi: medRxiv preprint (data not shown). It is possible that some antigen-specific T cells are not making cytokines in the 343 time frame analyzed or that some of these activation markers are induced on memory T cells by 344 bystander effects (cytokines). We suggest, that functional readouts based on cytokines may be 345 more relevant to understanding protective immunity to SARS-CoV-2 than use of activation 346 markers. between total N-specific T cells measured by ELISpot with neutralizing antibody titers. Of note, 354 total T effector responses to N and S as well as IFN-g or IFN-g and granzyme B responses to E 355 and M peptide pools also correlated with virus neutralization, suggesting that a strong CD4+ T cell 356 response in general correlated with effective virus neutralization, whether we used peptide pools 357 or intact antigens for these recall assays. Of note, 100% of donors showed pTfh responses to 358 influenza virus and the response was generally of higher frequency. Thus, the Tfh response to 359 SARS-CoV-2 in convalescent subjects is weaker than that observed in response to influenza virus 360 restimulation. 361 362 Several recent studies have revealed responses of healthy donors to SARS-CoV-2 peptides (21-363 23, 28, 31). It has also been suggested that prior exposure to seasonal coronaviruses might allow 364 some cross-protective immunity to SARS-CoV-2 (30). Our ICC assays did not reveal responses 365 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted September 1, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted September 1, 2020. . https://doi.org/10.1101/2020.08.27.20183319 doi: medRxiv preprint fell off gradually (54). We did not see a consistent difference between severe and mild cases in 389 terms of magnitude of the T cell response, albeit this may be limited by sample size. 390

In sum, our study shows robust T cell recall responses in SARS-CoV-2 convalescent subjects at potentially contributing to disease. The strong correlation between the N-or S-specific pTfh 401 response or the IFN-g/granzyme B+ proliferative response and neutralization capacity suggests 402 that these responses should be incorporated into vaccine design and testing. 403

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted September 1, 2020. 

The human codon-optimized cDNA encoding the OC43 spike protein (AAT84354.1) was 420 synthesized by GeneArt. The soluble OC43 spike construct includes residues 15-1295, followed 421 by a T4 fibritin trimerization motif, a TEV cleavage site, and a 6xHis-tag. The 20 amino acid 422 human cystatin secretion signal was added N-terminal to the spike sequence. To stabilize the pre-423 fusion state of the OC43 spike trimer, residues 1070-1071 (AL) were mutated to two proline 424 residues (PP) as described for other spike proteins (55). The human codon-optimized cDNA 425 encoding the SARS-CoV-2 spike protein (YP_009724390) was synthesized by GenScript. The 426 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted September 1, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted September 1, 2020. were either cultured with complete media, 100 HAU/ml PR8 or 1 μg/ml TIV for 18h. To determine 470 whether the addition of agonistic co-stimulatory antibodies increased the sensitivity of detection 471 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted September 1, 2020. . https://doi.org/10.1101/2020.08.27.20183319 doi: medRxiv preprint of ICC by flow cytometry, PBMCs were stimulated with 1ug/ml S or 1 μg/ml BSA, either with or 472 without 2 μg/ml anti-CD28 and 2 μg/ml anti-CD49d (BD Biosciences) for 18h. GolgiStop and 473

GolgiPlug were added in the last 6h of these cultures. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted September 1, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted September 1, 2020. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted September 1, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted September 1, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted September 1, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted September 1, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted September 1, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted September 1, 2020. Sidak's multiple comparisons test. *p<0.05, **p<0.01, ****p<0.0001. 767 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted September 1, 2020. were normalized to a positive control well. Pair-wise comparisons were made by two-tailed 786

Wilcoxon test for (A). Correlation analysis for (C)-(E) was performed by Pearson's correlation. 787 ***p<0.001. 788

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted September 1, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted September 1, 2020. frequency of CD4+ and CD8+ T cells within CFSE low CD3+ T cells in each patient. 810 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted September 1, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted September 1, 2020. . https://doi.org/10.1101/2020.08.27.20183319 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted September 1, 2020. TNF-α, and IL-2 responses to OC43 S and PMA/Ionomycin (n=13), gated on non-pTfh CD4+ T 831 cells. Pair-wise comparisons were made by two-tailed Wilcoxon test. ***p<0.001. 832

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted September 1, 2020. test was performed for (A) and (B). Two-way ANOVA was used to compare control and spike 841 stimulated CD4+ T cells with or without co-stimulatory antibodies in (C). *p<0.05, **p<0.01. 842 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted September 1, 2020. . https://doi.org/10.1101/2020.08.27.20183319 doi: medRxiv preprint 843 Figure S3 . Healthy donor intracellular cytokine responses to viral antigen by flow cytometry.

Representative flow cytometry plots and graphs for CD4+ T cell IFN-γ, TNF-a and IL-2 responses 845 are shown in response to S, N, OC43 S or PR8 (n=5). Pair-wise comparisons were made by two-846 tailed Wilcoxon test. **p<0.01, ****p<0.0001. 847 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted September 1, 2020. . https://doi.org/10.1101/2020.08.27.20183319 doi: medRxiv preprint Figure S4 . Cytokines secreted in response to PR8 and SARS-CoV-2 antigens. Graphs show 849 levels of (A) TNF-α, IFN-γ, IL-2, IL-10, IL-6 and IL-13, (B) IL-9, IL-17A and IL-22 in SARS-850

CoV-2 convalescent PBMC cultures (n=13), and (C) levels of IFN-γ, TNF-α, IL-2, IL-10, IL-13 851 and IL-6 in healthy donor PBMC cultures (n=3) in response to S, N or PR8. Nonparametric Dunn's 852 multiple comparisons test was performed for (A). Pair-wise comparisons were made by two-tailed 853

Wilcoxon test in (B) and (C). OM8099 exhibited high background TNF-α and was determined to 854 be an outlier by the Grubb's test. Although this data point is shown in all panels, it was excluded 855 from statistical analysis of TNF-α responses. Graphs show mean±SD. *p<0.05, **p<0.01, 856 ***p<0.001, ****p<0.0001. 857 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted September 1, 2020. tailed Wilcoxon test. *p<0.05, **p<0.01, ***p<0.001. 862

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted September 1, 2020. . https://doi.org/10.1101/2020.08.27.20183319 doi: medRxiv preprint 863 864 Figure S6 . Flow cytometry gating strategy for T cells proliferative assay. Representative 865 gating strategy for CFSE low CD3+ T cells, CD4+/CD8+ T cells and IFN-g/Granzyme B producing 866 CD4+ /CD8+ T cells. 867

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted September 1, 2020. . https://doi.org/10.1101/2020.08.27.20183319 doi: medRxiv preprint 

A Novel Coronavirus from 580 Patients with Pneumonia in China

A pneumonia outbreak 582 associated with a new coronavirus of probable bat origin

A new coronavirus associated 584 with human respiratory disease in China

CoV-2 infection protects against rechallenge in rhesus macaques

Lack of Reinfection in Rhesus 589

Macaques Infected with SARS-CoV-2

SARS-CoV-2 in patients with COVID-19

Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in 601

Breadth of concomitant immune responses prior to patient recovery: a case report of non-604 severe COVID-19

Detection of SARS-CoV-2-606

Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals

Dynamics of 609 neutralizing antibody titers in the months after SARS-CoV-2 infection

SARS-CoV-2 infection 612 induces robust, neutralizing antibody responses that are stable for at least three months

Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19. N Engl J 616 Med 101056

CoV-2-specific immune memory persists after mild COVID-19

Evidence for sustained mucosal 624 and systemic antibody responses to SARS-CoV-2 antigens in COVID-19 patients

T follicular helper cell differentiation, function, and roles in disease

Lack of peripheral memory B 629 cell responses in recovered patients with severe acute respiratory syndrome: a six-year 630 follow-up study

Memory T cell 632 responses targeting the SARS coronavirus persist up to 11 years post-infection

SARS-CoV-2-635 specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. 636

Targets 638 of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease 639 and Unexposed Individuals

Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with 642 acute respiratory distress syndrome

Direct ex vivo analysis of human 666

CD4(+) memory T cell activation requirements at the single clonotype level

Follicular helper CD4 T cells (TFH)

Circulating precursor 670

CCR7(lo)PD-1(hi) CXCR5(+) CD4(+) T cells indicate Tfh cell activity and promote 671 antibody responses upon antigen reexposure

Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain 674 specific subsets that differentially support antibody secretion

A simple protein-677 based SARS-CoV-2 surrogate neutralization assay

Polyfunctional HCV-specific T-cell responses are associated with effective control of 681 HCV replication

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

Characterization of the CD4+ T cell response to Epstein-Barr virus during primary and 687 persistent infection

The physiological role of cytotoxic CD4(+) T-cells: the holy grail

Human cytotoxic T-lymphocyte repertoire to influenza 691 A viruses

Marked T 693 cell activation, senescence, exhaustion and skewing towards TH17 in patients with 694 COVID-19 pneumonia

Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)

Epigenetic Regulation of T Cell Memory: 699 Recalling Therapeutic Implications

Suppression of antigen presentation by IL-10

Clinical and immunological 703 features of severe and moderate coronavirus disease 2019

COVID-19 and influenza highlights the role of type I interferons in development of 707 severe COVID-19

Next-Generation Sequencing of T and B Cell Receptor Repertoires from COVID-19

Patients Showed Signatures Associated with Severity of Disease. Immunity. 2020

IgA dominates the early 712 neutralizing antibody response to SARS-CoV-2

A comparison of the antigen-715 presenting capabilities of class II MHC-expressing human lung epithelial and endothelial 716 cells

Evidence for accessory cell function by 718 class II MHC antigen-expressing airway epithelial cells

Expression and Its Role in Antigen Presentation in the Gastrointestinal and Respiratory 722

Acute SARS-CoV-2 infection 724 impairs dendritic cell and T cell responses

Humoral and cell-mediated immunity to pandemic H1N1 influenza in a Canadian cohort 728 one year post-pandemic: implications for vaccination

Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike 731 antigen

Site-specific biotinylation of purified proteins using BirA